FDA Highlights: Viagra appears to be cardioprotective
by Bruce Sylvester – Viagra® (sildenafil citrate) might be useful in safely treating heart disease, researchers reported on Oct. 19, 2014 in l BMC Medicine. The study suggests that… read more.
by Bruce Sylvester – Viagra® (sildenafil citrate) might be useful in safely treating heart disease, researchers reported on Oct. 19, 2014 in l BMC Medicine. The study suggests that… read more.
by Bruce Sylvester: Patients with familial hypercholesterolaemia (FH) who are being treated with statins have achieved additional lowering of LDL cholesterol with adjuvant evolocumab therapy, researchers reported on… read more.
This webinar covers various topics including: Heart Failure definition, Epidemiology & Aetiology / NYHA classification / CHF treatment overview / Reviewing CHF patients. This webinar was initiated and… read more.
by Bruce Sylvester – Researchers report that metformin therapy, a treatment for type 2 diabetes, could induce a lowering thyroid-stimulating hormone (TSH) in patients with underactive thyroids (hypothyroidism)…. read more.
by Bruce Sylvester – Following heart attack, patients who undergo revascularization of all significantly blocked arteries achieve better outcomes than patients who undergo revascularization of the “culprit” artery… read more.
by Bruce Sylvester: After 13 months of high-dose statin therapy, STEMI (ST Segment Elevation Myocardial Infarction) patients achieved significant reductions in coronary atherosclerosis, researchers reported on Sept. 2,… read more.
by Bruce Sylvester: Two intravenous doses of an iron supplement appears to cause heart failure patients with iron deficiency to achieve significant improvements in functional capacity, quality of… read more.
Report from the ESC Annual Congress by Bruce Sylvester: The investigational monoclonal antibody alirocumab, which significantly lowers cholesterol on top of regular statin therapy, also lowers the incidence… read more.
Report from the European Society of Cardiology Annual Congress in Barcelona by Bruce Sylvester – Results from the PARADIGM-HF trial, presented at ESC 2014 on August 30,2014 and… read more.
by Bruce Sylvester: Fenofibrate treatment reduces cardiovascular disease risks in persons with type-2 diabetes, especially women, researchers reported on August 18 in Diabetologia.
by Bruce Sylvester – Researchers report that routinely monitoring the pulse of anyone who has had a stroke could detect irregular heartbeat, a major cause of second stroke…. read more.
by Bruce Sylvester – Elevated systolic and diastolic blood pressure appear to be predictive of different cardiovascular diseases and at different ages, researchers reported in a special themed… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.